FXIII deficiency due to base exchange Thr 449 (ACT) > Ile (ATT) in exon 11 of the factor 13A gene: A cause of bleeding?

Hamostaseologie

Volumn 30, Issue 3, 2010, Pages 162-164

  Maak, B ^a   Kochhan, L ^b   Heuchel, P ^c   Jenderny, J ^b  

^a ThUringen Kliniken   (Germany)

^b Abteilung Humangenetik   (Germany)

^c Labor Dr Heuchel   (Germany)

Author keywords

Bleeding tendency; Factor xiii deficiency; Low von willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 13A; VON WILLEBRAND FACTOR; BLOOD CLOTTING FACTOR 13;

ADOLESCENT; ALLELE; ARTICLE; BLOOD CLOTTING FACTOR 13 DEFICIENCY; CASE REPORT; EPISTAXIS; EXON; GENETIC ANALYSIS; GINGIVA BLEEDING; HETEROZYGOTE; HUMAN; MALE; PROTEIN FUNCTION; SKIN BLEEDING; UROLOGIC SURGERY; AMINO ACID SUBSTITUTION; BLEEDING; BLOOD; BLOOD GROUP ABO SYSTEM; FEMALE; GENETICS; NUCLEAR FAMILY; SINGLE NUCLEOTIDE POLYMORPHISM;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; AMINO ACID SUBSTITUTION; EXONS; FACTOR XIII; FACTOR XIII DEFICIENCY; FEMALE; HEMORRHAGE; HUMANS; MALE; NUCLEAR FAMILY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 77957014170     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619046     Document Type: Article

References (11)

1. Beck EA. Klinische Bedeutung einer subnormalen Aktivität des von Willebrand-Proteins. In: Scharrer I, Schramm W (Hrsg). 24. Hämophilie- Symposion Hamburg 1993, Berlin, Heidelberg: Springer 1994; 402-405.
2. Di Paola J, Federici AB, Mannucci PM et al. Low platelet alpha 2 beta 1 levels in type I von Willebrand disease. Blood 1999; 93: 3578-3582.
3. Duckert F, Jung E, Shmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilising factor deficiency. Thromb Diathes Haemorrh 1960; 5: 179-186.
4. Girolami A, Capellato MG, Vicarioto MA. Congenital factor XIII deficiency: type I and type II disease. Brit J Haematol 1985; 60: 375-391.
5. Ichinose A: Physiopathology and regulation of factor XIII. Thromb Haemost 2001; 86: 57-65.
6. Ivaskevicius V, Seitz R, Kohler HP et al. and the study group: International registry of factor XIII deficiency: A basis formed mostly on European data. Thromb Haemost 2007; 97: 914-921.
7. Kitchens CS, Newcomb TS: Factor XIII. Medicine 1979; 58: 413-429.
8. Mc Donagh J, Mc Donagh RP, Myllyla G, Ikkala E. Factor XIII deficiency: a genetic study of two affected kindreds in Finland. Blood 1974; 43: 327-332.
9. Oldenburg J, Schwaab R, Wöhrle N et al. Bedeutung der Blutgruppen-H-Substanz für den v.Willebrand Faktor/Faktor VIII-Komplex. In: Scharrer I, Schramm W (Hrsg). 23. Hämophilie-Symposion Hamburg 1992, Berlin, Heidelberg: Springer 1993: 252-256.
10. Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 2089-2093. (Pubitemid 36302041)
11. Weiss HJ. The bleeding tendency in patients with low von Willebrand factor and type 1 phenotype is greater in the presence of impaired collagen-induced platelet aggregation. J Thromb Haemost 2004; 2: 198-199.